| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.16 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.5 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |